Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Kowa Research Institute, Inc.
Age
18–45
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Subject provides written informed consent before any study-specific evaluation is performed.
Subject is a healthy adult male or a female of non-childbearing potential between the ages of 18 and 45 years, inclusive.
Subject has a body mass index of 18.5 to 30 kg/m2, inclusive.
Subject has hematology, coagulation, serum chemistry, and urinalysis test results within the reference ranges or showing no clinically relevant deviations, as judged by the Investigator.
You may not be if
Subject has the presence of an active or recurring clinically significant cardiovascular, pulmonary, renal, endocrine, hepatic, neurologic, psychiatric, immunologic, hematologic, gastrointestinal, or metabolic disease requiring medical treatment.
Subject has any surgical or medical condition that might significantly alter the absorption, distribution, metabolism, or excretion of K-312. Cholecystectomy is permitted if there are no postcholecystectomy gastrointestinal symptoms.
Subject has clinically relevant abnormalities in clinical laboratory parameters.
